Open AccessLow stroke rate and few thrombo-embolic events after HeartMate II implantation under mild anticoagulation
Author(s) -
Ares Krishna Me,
Andreas Götzenich,
Helena Saßmannshausen,
M. Haushofer,
Rüdiger Autschbach,
Jan Spillner
Publication year - 2012
Publication title -
european journal of cardio-thoracic surgery
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.303
H-Index - 133
eISSN - 1873-734X
pISSN - 1010-7940
DOI - 10.1093/ejcts/ezr312
Subject(s) - medicine , cardiology , stroke (engine) , heart failure , embolic stroke , ventricular assist device , adverse effect , embolism , regimen , surgery , ischemic stroke , mechanical engineering , engineering , ischemia
Bleeding and thrombo-embolism are two of the most threatening adverse events associated with the use of continuous flow left ventricular assist devices (LVADs) in the treatment of severe heart failure. We analysed our LVAD patients treated with the HeartMate II (HM II) device by following a low anticoagulation regimen.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom